Farms.com Home   News

Latest Beef Quality Audit Shows Improvements

The National Beef Quality Audit (NBQA) delivers a set of guidelines and measurements for producers and other stakeholders to help determine the quality conformance of the beef supply. Results from the 2022 audit indicate the industry is producing a high-quality product consumers want and the focus of the supply chain remains food safety. 

Early audits focused on attributes like marbling, external fat and carcass blemishes. This list has evolved to include food safety, sustainability, animal well-being and the growing disconnect between producers and consumers. As a result, NBQA has made changes to the research, leading to an increasingly meaningful set of results. 

Based on interviews with industry stakeholders, as well as in-plant research, some of the key findings from the 2022 audit include:
• Market segments no longer consider food safety a purchasing criterion, but an expectation.
• When comparing 2016 and 2022 audits, the largest improvement was increased efficiency across the beef supply chain.
• An increase in usage of electronic identification.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.